Ticker Details
Exagen Inc.
IPO Date:	September 20, 2019
Sector:	Healthcare
Industry:	Diagnostics and Research
Market Cap:	$191.86M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.32 | 4.01%
Avg Daily Range (30 D):	$0.23 | 4.51%
Avg Daily Range (90 D):	$0.22 | 5.01%

Institutional Daily Volume
Avg Daily Volume:	.1M
Avg Daily Volume (30 D):	.36M
Avg Daily Volume (90 D):	.37M

Trade Size
Avg Trade Size (Sh.):	103
Avg Trade Size (Sh.) (30 D):	84
Avg Trade Size (Sh.) (90 D):	92

Institutional Trades
Total Institutional Trades:	78
Avg Institutional Trade:	$1.74M
Avg Institutional Trade (30 D):	$2.02M
Avg Institutional Trade (90 D):	$1.44M
Avg Institutional Trade Volume:	.17M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.09M
Avg Closing Trade (30 D):	$.54M
Avg Closing Trade (90 D):	$.57M
Avg Closing Volume:	208.08K

News

Feb 24, 2026 @ 2:00 PM Exagen Inc. to Announce Fourth Quarter and Full Ye... Source: Na

Jan 11, 2026 @ 8:00 PM Exagen Inc. Announces Select Preliminary 2025 Fina... Source: Na

Nov 11, 2025 @ 2:00 PM Exagen Inc. to Participate in Fourth Quarter Inves... Source: Ryan Douglas

Jun 13, 2024 @ 12:50 PM Why Fast-paced Mover Exagen (XGN) Is a Great Choic... Source: Zacks Equity Research

Jun 10, 2024 @ 12:03 PM Time to Play 5 Top-Ranked Stocks With Rising P/E? Source: Sanghamitra Saha

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.81	$-.13	$-.17
Diluted EPS	$-.81	$-.13	$-.17
Revenue	$71.12M	$19.94M	$17.31M
Gross Profit	$41.7M	$12.22M	$10.21M
Net Income / Loss	$-18.92M	$-3.2M	$-3.97M
Operating Income / Loss	$-13.21M	$-1.72M	$-3.41M
Cost of Revenue	$29.42M	$7.72M	$7.1M
Net Cash Flow	$-5.45M	$3.08M	$-10.71M
PE Ratio